Pfizer to Provide Australia with 500,000 Courses of Oral Treatment for COVID-19
Pfizer Australia transitions to wholesaler distribution model
Pfizer and BioNTech Achieve Approval by Medsafe For Their Vaccine Against COVID-19
Pfizer and BioNTech Achieve Approval by TGA for Their Vaccine Against COVID-19
Accredited journalists can contact the Pfizer Australia & New Zealand Media Relations team at: email@example.com.
Please note that this email address is intended specifically for journalists with media enquiries and unfortunately, we are unable to respond to any non-media enquiries sent to this address.